News Conference News TCT 2017 MAVERIC: Transcatheter MV Repair Shows Continued Efficacy, Safety at 6 Months TCT Daily Staff November 06, 2017
Presentation TCT 2014 Initial Results of the Mitral Valve Repair Clinical Trial (MAVERIC Trial) Utilizing Percutaneous Septal Sinus Shortening (The MVRx System) for the Treatment of Functional Mitral Regurgitation Presenter: Francesco Maisano, Gregg W. Stone, Brian K. Whisenant, Andrejs Erglis September 14, 2014